Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	4.78	19.21	42.27	24.67	22.49	48.61
Short-Term Investments	-	-	-	-	33.78	-
Cash & Short-Term Investments	4.78	19.21	42.27	24.67	56.28	48.61
Cash Growth	-80.55%	-54.56%	71.35%	-56.17%	15.78%	102.11%
Other Receivables	-	-	-	-	0.03	0.02
Receivables	-	-	-	-	0.03	0.02
Prepaid Expenses	0.25	0.09	0.12	0.17	0.22	0.25
Restricted Cash	0.22	0.26	0.3	0.06	0.04	0.05
Other Current Assets	0.39	0.57	0.79	1	1.15	1.42
Total Current Assets	5.63	20.13	43.48	25.89	57.71	50.34
Property, Plant & Equipment	0.41	0.99	1.66	0.55	1.13	0.25
Other Long-Term Assets	-	-	-	0.03	0.11	0.13
Total Assets	6.04	21.12	45.14	26.48	58.95	50.72
Accounts Payable	3.13	3.02	1.38	0.48	1.87	0.75
Accrued Expenses	2.44	2.8	4.2	2.67	4.66	6.94
Short-Term Debt	12.97	12.54	3.72	0.81	0.4	-
Current Portion of Long-Term Debt	2.82	3.98	-	5.24	4.34	-
Current Portion of Leases	0.32	0.71	0.66	0.39	0.5	-
Current Income Taxes Payable	-	-	-	-	0.04	0.12
Other Current Liabilities	1.79	0.05	-	0.26	-	-
Total Current Liabilities	23.47	23.09	9.96	9.84	11.81	7.81
Long-Term Debt	2.62	8.56	12	6.38	10.5	-
Long-Term Leases	0	0.14	0.8	0.03	0.43	-
Total Liabilities	26.09	31.78	22.76	16.25	22.73	7.81
Common Stock	0.03	0.02	0.02	0.4	0.4	0.36
Additional Paid-In Capital	268.47	263.71	262.88	183.25	174.52	129.83
Retained Earnings	-288.55	-274.39	-238.32	-171.6	-137.02	-86.15
Treasury Stock	-	-	-2.19	-1.83	-1.7	-1.13
Comprehensive Income & Other	-	-	-	-	0.02	-
Total Common Equity	-20.05	-10.66	22.38	10.23	36.21	42.91
Shareholders' Equity	-20.05	-10.66	22.38	10.23	36.21	42.91
Total Liabilities & Equity	6.04	21.12	45.14	26.48	58.95	50.72
Total Debt	18.72	25.92	17.18	12.84	16.17	-
Net Cash (Debt)	-13.95	-6.71	25.09	11.83	40.11	48.61
Net Cash Growth	-	-	112.14%	-70.52%	-17.48%	102.11%
Net Cash Per Share	-6.00	-3.10	14.34	11.79	42.15	59.94
Filing Date Shares Outstanding	3.14	2.17	2.17	1.01	1	0.9
Total Common Shares Outstanding	3.07	2.17	2.17	1	1	0.9
Working Capital	-17.84	-2.96	33.53	16.06	45.9	42.53
Book Value Per Share	-6.53	-4.92	10.33	10.19	36.19	47.86
Tangible Book Value	-20.05	-10.66	22.38	10.23	36.21	42.91
Tangible Book Value Per Share	-6.53	-4.92	10.33	10.19	36.19	47.86
Machinery	-	0.29	0.28	0.29	0.33	0.31
Construction In Progress	-	-	0.02	-	-	-
Leasehold Improvements	-	0.06	0.09	0.16	0.16	0.14

Source: S&P Capital IQ. Standard template. Financial Sources.